Patent · US Active

Norepinephrine compositions and methods therefor

US10568850B2 · kind B2 · utility

3Cited by

6References

19Claims

0Family size

Assignee

NEUVANA, LLC · US

Inventors

Tushar Hingorani · Bound Brook Junction, US
Prem Sagar Akasapu · Edison, US
Kumaresh Soppimath · Colts Neck Township, US

Key dates

Filing date	Jan 3, 2019
Grant date	Feb 25, 2020
Priority date	—
Expiry date	Jan 3, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.